Jump to content

Receptor activity-modifying protein

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Flikr (talk | contribs) at 16:42, 12 December 2008 (Protein-protein interactions added.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Receptor activity-modifying protein 1
Identifiers
SymbolRAMP1
NCBI gene10267
HGNC9843
OMIM605153
RefSeqNM_005855
UniProtO60894
Other data
LocusChr. 2 q36-37.1
Search for
StructuresSwiss-model
DomainsInterPro
Receptor activity-modifying protein 2
Identifiers
SymbolRAMP2
NCBI gene10266
HGNC9844
OMIM605154
RefSeqNM_005854
UniProtO60895
Other data
LocusChr. 17 q12-21.1
Search for
StructuresSwiss-model
DomainsInterPro
Receptor activity-modifying protein 3
Identifiers
SymbolRAMP3
NCBI gene10268
HGNC9845
OMIM605155
RefSeqNM_005856
UniProtO60896
Other data
LocusChr. 7 q13-p12
Search for
StructuresSwiss-model
DomainsInterPro

Receptor activity-modifying proteins (RAMPs) are a class of protein which interact with and modulate the activities of several Class B G Protein-Coupled Receptors including the receptors for secretin, calcitonin (CT), glucagon, and vasoactive intestinal peptide (VIP).[1] There are three distinct types of RAMPs, designated RAMP1, RAMP2, and RAMP3, each encoded by a separate gene.[2]

Association of RAMPs with either the CT or CALCRL proteins form 6 different receptors from the calcitonin receptor family [3].

CALCRL...:[4][5]

CT... :

  • "Calcitonin Receptors". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. {{cite web}}: Cite has empty unknown parameter: |coauthors= (help)
  • Receptor+activity+modifying+protein at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

References

  1. ^ Sexton PM, Morfis M, Tilakaratne N, Hay DL, Udawela M, Christopoulos G, Christopoulos A (2006). "Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs". Ann N Y Acad Sci. 1070: 90–104. doi:10.1196/annals.1317.076. PMID 16888151.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. ^ Young A (2005). "Amylin: Physiology and Pharmacology; Chapter 3: Receptor pharmacology". Advances in Pharmacology. 52: 47–65. doi:10.1016/S1054-3589(05)52003-9. PMID 16492540.
  3. ^ *"Calcitonin Receptors: Introduction". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. {{cite web}}: Cite has empty unknown parameter: |coauthors= (help)
  4. ^ McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (1998). "RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor". Nature. 393 (6683): 333–9. doi:10.1038/30666. PMID 9620797. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  5. ^ Foord SM, Marshall FH (1999). "RAMPs: accessory proteins for seven transmembrane domain receptors". Trends Pharmacol. Sci. 20 (5): 184–7. doi:10.1016/S0165-6147(99)01347-4. PMID 10354609. {{cite journal}}: Unknown parameter |month= ignored (help)
  6. ^ Kamitani S, Asakawa M, Shimekake Y, Kuwasako K, Nakahara K, Sakata T (1999). "The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells". FEBS Lett. 448 (1): 111–4. doi:10.1016/S0014-5793(99)00358-0. PMID 10217420. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)